|
π
|
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.
18 auth.
P. Valent,
A. Klion,
H. Horny,
F. Roufosse,
J. Gotlib,
P. Weller,
A. Hellmann,
G. Metzgeroth,
K. Leiferman,
M. Arock,
...
J. Butterfield,
W. Sperr,
K. Sotlar,
P. Vandenberghe,
T. Haferlach,
H. Simon,
A. Reiter,
G. Gleich
|
9 |
2012 |
9
π
|
|
π
|
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.
20 auth.
P. Ogbogu,
B. Bochner,
J. Butterfield,
G. Gleich,
J. HussβMarp,
J. Kahn,
K. Leiferman,
T. Nutman,
F. Pfab,
J. Ring,
...
M. Rothenberg,
F. Roufosse,
Marie-Helene Sajous,
J. Sheikh,
D. Simon,
H. Simon,
M. Stein,
A. Wardlaw,
P. Weller,
A. Klion
|
9 |
2009 |
9
π
|
|
π
|
Treatment of patients with the hypereosinophilic syndrome with mepolizumab.
14 auth.
M. Rothenberg,
A. Klion,
F. Roufosse,
J. Kahn,
P. Weller,
H. Simon,
L. Schwartz,
L. Rosenwasser,
J. Ring,
E. Griffin,
...
A. Haig,
P. Frewer,
J. Parkin,
G. Gleich
|
9 |
2008 |
9
π
|
|
π
|
Refining the definition of hypereosinophilic syndrome.
10 auth.
H. Simon,
M. Rothenberg,
B. Bochner,
P. Weller,
A. Wardlaw,
M. Wechsler,
...
L. Rosenwasser,
F. Roufosse,
G. Gleich,
A. Klion
|
8 |
2010 |
8
π
|
|
π¦
|
Practical approach to the patient with hypereosinophilia.
F. Roufosse,
P. Weller
|
8 |
2010 |
8
π¦
|
|
π¦
|
Hypereosinophilic syndromes
F. Roufosse,
M. Goldman,
E. Cogan
|
7 |
2007 |
7
π¦
|
|
π¦
|
Pretreatment of psoriasis with the vitamin D3 derivative tacalcitol increases the responsiveness to 311βnm ultraviolet B: results of a controlled, right/left study
F. Roufosse,
Thierry Simonart,
Elie Cogan
|
7 |
2001 |
7
π¦
|
|
π¦
|
Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome
8 auth.
F. Roufosse,
L. SchandeneΜ,
C. Sibille,
K. Willard-Gallo,
B. Kennès,
A. Efira,
...
M. Goldman,
E. Cogan
|
7 |
2000 |
7
π¦
|
|
π
|
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias
16 auth.
P. Vandenberghe,
I. Wlodarska,
L. Michaux,
P. ZachΓ©e,
M. Boogaerts,
D. Vanstraelen,
M. Herregods,
A. Hoof,
D. Selleslag,
F. Roufosse,
...
M. Maerevoet,
G. Verhoef,
J. Cools,
D. Gilliland,
A. Hagemeijer,
P. Marynen
|
7 |
2004 |
7
π
|
|
π¦
|
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.
15 auth.
F. Roufosse,
J. Kahn,
G. Gleich,
L. Schwartz,
Anish D Singh,
L. Rosenwasser,
J. Denburg,
J. Ring,
M. Rothenberg,
J. Sheikh,
...
A. Haig,
S. Mallett,
D. Templeton,
H. Ortega,
A. Klion
|
7 |
2013 |
7
π¦
|
|
π¦
|
Lymphocytic variant hypereosinophilic syndromes.
F. Roufosse,
E. Cogan,
M. Goldman
|
7 |
2007 |
7
π¦
|
